Related references
Note: Only part of the references are listed.Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas
Joshua D. Schiffman et al.
CANCER RESEARCH (2010)
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Sonja J. Heidorn et al.
CELL (2010)
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos et al.
NATURE (2010)
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou et al.
NATURE (2010)
Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas
Margaret J. Dougherty et al.
NEURO-ONCOLOGY (2010)
Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation
J. P. Robinson et al.
ONCOGENE (2010)
Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours
K. Jacob et al.
BRITISH JOURNAL OF CANCER (2009)
Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas
Tim Forshew et al.
JOURNAL OF PATHOLOGY (2009)
Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma
J. Yu et al.
NEUROLOGY (2009)
Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma
D. T. W. Jones et al.
ONCOGENE (2009)
Tandem Duplication Producing a Novel Oncogenic BRAF Fusion Gene Defines the Majority of Pilocytic Astrocytomas
David T. W. Jones et al.
CANCER RESEARCH (2008)
Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development
Gergana Galabova-Kovacs et al.
JOURNAL OF CELL BIOLOGY (2008)
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas
Stefan Pfister et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
BRAFE600 in benign and malignant human tumours
C. Michaloglou et al.
ONCOGENE (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Further evidence for a somatic KRAS mutation in a Pilocytic astrocytoma
W. G. Janzarik et al.
NEUROPEDIATRICS (2007)
NRAS and BRAF mutations in melanoma turnours in re ation to clinical characteristics:: a study based on mutation screening by pyrosequencing
Esther Edlundh-Rose et al.
MELANOMA RESEARCH (2006)
Functional analysis of the regulatory requirements of B-Raf and the B-RafV600E oncoprotein
T. Brummer et al.
ONCOGENE (2006)
Biochemical and molecular characterization of the novel BRAFV599Ins mutation detected in a classic papillary thyroid carcinoma
S. Moretti et al.
ONCOGENE (2006)
Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
PTC Wan et al.
CELL (2004)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601
BH Zhang et al.
EMBO JOURNAL (2000)
Share Paper
